(11 days)
Not Found
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the description of the device and its function does not suggest the use of AI/ML.
No.
The device is for monitoring physiological data and detecting events, not for treating conditions.
Yes
The device is designed to acquire and monitor physiological data, process this data to detect ECG arrhythmia events and physiological parameter limit violations, and provide this information to clinicians, which directly supports diagnosis.
No
The device description explicitly lists multiple hardware components, including patient-worn transmitters, receiver antenna systems, receivers, and computer platforms, indicating it is not solely software.
Based on the provided information, the ApexPro Telemetry System is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- ApexPro Function: The ApexPro Telemetry System acquires and monitors physiological data directly from the patient (ECG, non-invasive blood pressure, SpO2) through patient-worn transmitters. It processes this data to detect events and violations.
- Lack of Sample Analysis: The description does not mention the analysis of any biological samples taken from the patient. The system is focused on real-time, non-invasive monitoring of physiological signals.
Therefore, the ApexPro Telemetry System falls under the category of a patient monitoring system, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.
The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2. The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display.
Product codes (comma separated list FDA assigned to the subject device)
MHX
Device Description
The ApexPro Telemetry System is composed of six major components:
• The patient worn data acquisition transmitters
• The receiver antenna system infrastructure
• The receivers
• The receiver subsystem
• A computer platform running the ApexPro Telemetry Application
• A computer platform running a central station application (which may be the same computer platform running the ApexPro Telemetry Application)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
licensed healthcare practitioner. The system is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Test Summary: The ApexPro complies with the voluntary standards as detailed in The following quality assurance Section 9 of this submission. measures were applied to the development of the system:
- Requirements specification review ●
- Code inspections .
- Software and hardware testing ●
- Safety testing .
- Environmental testing .
- Final validation .
- The results of these measurements demonstrated that the ApexPro Conclusion: THE Toodite of thous effective, and performs as well as the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K000779 ApexPro Telemetry System
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
MAY 0 7 2002
K021325
page 1 of 2
510(k) Summary of Safety and Effectiveness
ﺑ
,
:
| Date: | April 19, 2002 |
|---|---|
| Submitter: | GE Medical Systems Information Technologies |
| 8200 West Tower Avenue | |
| Milwaukee, WI 53223 USA | |
| Contact Person: | Joelle Neider |
| Regulatory Affairs Specialist | |
| GE Medical Systems Information Technologies | |
| Phone: 203-949-8232 | |
| Fax: 414-918-8113 | |
| Device: |
| |
| Trade Name: | ApexPro Telemetry System |
| Common/Usual Name: | Telemetry Monitoring System |
| Classification Names: | 21 CFR 870.1025 Detector and Alarm, Arrhythmia
21 CFR 870.2910 Transmitters & Receivers, Physiological Signal, Radio Frequency |
| Predicate Device: | K000779 ApexPro Telemetry System |
| Device Description: | The ApexPro Telemetry System is composed of six major components:
• The patient worn data acquisition transmitters
• The receiver antenna system infrastructure
• The receivers
• The receiver subsystem
• A computer platform running the ApexPro Telemetry Application
• A computer platform running a central station application (which may be the same computer platform running the ApexPro Telemetry Application) |
| Intended Use: | The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.
The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2. The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display. |
| Technology: | The ApexPro employs the same functional technology as the predicate devices. The system architecture has taken advantage of improvements in signal processing technology as well as advances in RF component technologies to improve performance and level of integration. |
1
K021325
page 2 of 2
Test Summary: The ApexPro complies with the voluntary standards as detailed in The following quality assurance Section 9 of this submission. measures were applied to the development of the system:
- Requirements specification review ●
- Code inspections .
- Software and hardware testing ●
- Safety testing .
- Environmental testing .
- Final validation .
- The results of these measurements demonstrated that the ApexPro Conclusion: THE Toodite of thous effective, and performs as well as the predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 0 7 2002
Ms. Joelle Neider Regulatory Affairs Specialist GE Medical Systems Information Technologies 8200 West Tower Avenue Milwaukee, WI 53223
Re: K021325
Trade Name: ApexPro Telemetry System Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm Regulatory Class: Class III (three) Product Code: MHX Dated: April 22, 2002 Received: April 26, 2002
Dear Ms. Neider:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Joelle Neider
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Dak Tiller Ph.D.
Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Page 1 of 1
510(k) Number (if known):
510(k) filed on April 19, 2002
Device Name:
ApexPro Telemetry System
Indications For Use:
The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for noulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.
The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2 The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use 7 (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Division of Cardiovascular & Respiratory Devices
510(k) Number K021325